Search

everythinglearnresearchcommunity

for

Search:↓

CuATSM speeds up wound healing and reduces scarring.

ASA and CM may protect the brain and work better together.

Healthcare access for alopecia areata in the USA is unequal among ethnic groups.

Reporter characteristics affect detection of hair loss from cancer therapy.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

PEDF reduces oxidative damage and supports stem cells.

Alopecia Areata affects young adults more in high-income countries, especially females.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

TRPV channels are important in osteoarthritis and could be key to new treatments.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

New treatments for seborrheic dermatitis show promise for difficult cases.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Autologous Micrografting Technology effectively improves hair growth and is a safe, promising option for hair restoration.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.

Polygonum multiflorum may help treat hair loss but can be toxic to the liver.